The FDA needs to step up its recruitment and retention efforts for investigators in the face of retirements and workers leaving as the number of on-site bioresearch monitoring (BIMO) inspections decreases, the Government Accountability Office (GAO) recommends. Three members of the House Committee on Energy and Commerce chair Cathy McMorris Rodgers, R-Wash., Brett Guthrie, R-Ky... Read More